Lunai Bioworks Inc. (LNAI)
NASDAQ: LNAI · Real-Time Price · USD
0.8255
-0.0667 (-7.48%)
At close: Oct 15, 2026, 4:00 PM EDT
0.8420
+0.0165 (2.00%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Lunai Bioworks Revenue
In the fiscal year ending June 30, 2026, Lunai Bioworks had annual revenue of $51.99K. Lunai Bioworks had revenue of $31.05K in the quarter ending June 30, 2026. That makes Lunai Bioworks the 46,500th largest company in the world by revenue and 6,940th in the United States.
Revenue (ttm)
$51.99K
Revenue Growth
n/a
P/S Ratio
79.93
Revenue / Employee
$1,793
Employees
29
Market Cap
4.16M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 51.99K | - | - |
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xenetic Biosciences | 3.26M |
| Lexaria Bioscience | 194.00K |
| AIM ImmunoTech | 95.00K |
| Jupiter Neurosciences | 64.69K |
| Azitra | 7.50K |
| Pulmatrix | 3.00K |
| Creative Medical Technology Holdings | 3.00K |
LNAI News
- 2 days ago - Lunai Bioworks Annual report: Q4 2026 - Filings
- 23 days ago - Lunai Bioworks expands Parkinson’s platform through agreement with Tanaist - TheFly
- 23 days ago - Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement - PRNewsWire
- 4 weeks ago - Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI - PRNewsWire
- 5 weeks ago - Lunai Bioworks (NASDAQ: LNAI) Issues Correction to Press Release Regarding Second Amended Complaint - PRNewsWire
- 7 weeks ago - Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit - PRNewsWire
- 2 months ago - Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement with BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 - PRNewsWire
- 2 months ago - Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit - PRNewsWire